文化大學機構典藏 CCUR:Item 987654321/52783
English  |  正體中文  |  简体中文  |  全文笔数/总笔数 : 46962/50828 (92%)
造访人次 : 12475023      在线人数 : 503
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 查询小技巧:
  • 您可在西文检索词汇前后加上"双引号",以获取较精准的检索结果
  • 若欲以作者姓名搜寻,建议至进阶搜寻限定作者字段,可获得较完整数据
  • 进阶搜寻
    主页登入上传说明关于CCUR管理 到手机版


    jsp.display-item.identifier=請使用永久網址來引用或連結此文件: https://irlib.pccu.edu.tw/handle/987654321/52783


    题名: 企業與可持續發展績效之間的關係以及環境、社會和治理的調節作用:製藥行業的證據
    The Relationship between Corporate and Sustainability Performance and Moderating Role of Environmental, Social, and Governance: Evidence in the Pharmaceutical Industry
    作者: 葉冠山
    YULIANTO, SHANDY
    贡献者: 全球商務碩士學位學程碩士班
    关键词: The two stage dynamic DEA
    日期: 2023
    上传时间: 2023-07-31 15:51:39 (UTC+8)
    摘要: Sustainability Performance (SP) contributions are critical for corporate profit when considering long-term economic growth, but they also impose additional financial constraints for many firms. This thesis examines the association amid pharmaceutical firms' SP and corporate performance (CP) using data from 150 pharmaceutical listed companies from 2016 to 2020. Furthermore, corporate social responsibility (CSR) is classified as environmental, social, and governance in order to investigate its moderating influence on SP and CP. SP appears to have a favorable and considerable influence on CP in pharmaceutical listed companies. According to the findings, a higher social pillar score (SPS) can accelerate the good effect of SP on CP. Furthermore, in terms of region, the American faction surpasses the other factions regarding sustainability and corporate performance. These findings give theoretical and practical benchmarks for CSR managem
    显示于类别:[全球商務學位學程] 博碩士論文

    文件中的档案:

    档案 描述 大小格式浏览次数
    index.html0KbHTML115检视/开启


    在CCUR中所有的数据项都受到原著作权保护.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回馈